Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
This study has been completed.
Sponsor:
Nationwide Children's Hospital
Collaborator:
Asklepios Biopharmaceutical, Inc.
Information provided by (Responsible Party):
Jerry R. Mendell, Nationwide Children's Hospital
ClinicalTrials.gov Identifier:
NCT00428935
First received: January 26, 2007
Last updated: February 4, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2010 |
| Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Publications: